Back
  1. Home
  2. Profile of Gianni Maggipinto (ULiège)
Profil

Maggipinto Gianni

See author's contact details
Main Referenced Co-authors
Gerard, Christiane  (15)
Vaira, Dolorès  (11)
Belaiche, Jacques  (10)
Delwaide, Jean  (10)
Rentier, Bernard  (10)
Main Referenced Keywords
Humans (3); cell therapy (2); COVID-19 (2); ABO (1); ABO Blood-Group System (1);
Main Referenced Unit & Research Centers
CEIB - Centre Interfacultaire des Biomatériaux - ULiège (1)
Main Referenced Disciplines
Immunology & infectious disease (13)
Gastroenterology & hepatology (7)
Surgery (5)
Hematology (3)
Oncology (2)

Publications (total 23)

The most downloaded
803 downloads
Gielen, S., Delwaide, J., Detry, O., Belaiche, J., Honore, P., Gerard, C., Maggipinto, G., Vaira, D., & Rentier, B. (2001). Comment je traite une ascite. Revue Médicale de Liège, 56 (12), 809-815. https://hdl.handle.net/2268/69781

The most cited

152 citations (OpenAlex)

Gérard, C., MAGGIPINTO, G., & Minon, J.-M. (2020). COVID-19 and ABO blood group: another viewpoint. British Journal of Haematology, 190 (2), 93-e94. doi:10.1111/bjh.16884 https://hdl.handle.net/2268/249794

Gerard, C., MAGGIPINTO, G., & Minon, J.-M. (July 2022). Is 'ABO-D' really a ready-made package? Why these parameters should be analysed separately in correlation studies? British Journal of Haematology, 198 (2), 26-e27. doi:10.1111/bjh.18222
Peer Reviewed verified by ORBi

VANDERMEULEN, M., Mohamed-Wais, M., ERPICUM, P., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., MAGGIPINTO, G., Jouret, F., Beguin, Y., & Detry, O. (2022). Infusion of allogeneic mesenchymal stromal cells after liver transplantation: Five-year follow-up. Liver Transplantation, 28, 636-646. doi:10.1002/lt.26323
Peer reviewed

VANDERMEULEN, M., Mohamed Wais, M., DELBOUILLE, M.-H., MAGGIPINTO, G., BEGUIN, Y., & DETRY, O. (August 2021). Long term follow-up of liver transplant recipients after allogeneic mesenchymal stromal cell infusion. Transplant International, 34 (S1 OP282), 45.
Peer Reviewed verified by ORBi

Gérard, C., MAGGIPINTO, G., & Minon, J.-M. (2020). COVID-19 and ABO blood group: another viewpoint. British Journal of Haematology, 190 (2), 93-e94. doi:10.1111/bjh.16884
Peer Reviewed verified by ORBi

ERPICUM, P., WEEKERS, L., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., GREGOIRE, C., BAUDOUX, E., BRIQUET, A., LECHANTEUR, C., MAGGIPINTO, G., SOMJA, J., Pottel, H., Baron, F., Jouret, F., & BEGUIN, Y. (2019). Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study. Kidney International, 95, 693-707. doi:10.1016/j.kint.2018.08.046
Peer Reviewed verified by ORBi

VANDERMEULEN, M., MAGGIPINTO, G., JOURET, F., BEGUIN, Y., & DETRY, O. (September 2017). DO MESENCHYMAL STROMAL CELLS PROMOTE HLA SPECIFIC ANTIBODIES FORMATION AFTER INFUSION IN LIVER TRANSPLANT RECIPIENTS? Transplant International, 30 (S2), 548 (PLB051.
Peer Reviewed verified by ORBi

MONFORT, M., PEYRARD, T., ARNAUD, L., HELIAS, V., MAGGIPINTO, G., & GERARD, C. (December 2013). Un allèle KEL*02mod responsable d'une exclusion apparente de maternité. Transfusion Clinique et Biologique, 20, 490-5. doi:10.1016/j.tracli.2013.03.278
Peer Reviewed verified by ORBi

Cerda Cristerna, B. I., COTTIN, S., Flebus, L., Pozos-Guillén, A., Flores, H., Heinen, E., Jolois, O., GERARD, C., MAGGIPINTO, G., Sevrin, C., & Grandfils, C. (2012). Poly(2-dimethylamino ethylmethacrylate)-Based Polymers To Camouflage Red Blood Cell Antigens. Biomacromolecules, 13 (4), 1172-1180. doi:10.1021/bm300127f
Peer Reviewed verified by ORBi

Putzeys, V., GERARD, C., Bastens, B., Wain, E., Bataille, C., Defrance, P., Belaiche, J., DE ROOVER, A., DETRY, O., Honoré, P., MAGGIPINTO, G., Rentier, B., VAIRA, D., & DELWAIDE, J. (2011). Hepatitis C of genotype 2: the role of medical invasive exams. Acta Gastro-Enterologica Belgica, 74 (2), 277-80.
Peer Reviewed verified by ORBi

Gielen, S., Delwaide, J., Detry, O., Belaiche, J., Honore, P., Gerard, C., Maggipinto, G., Vaira, D., & Rentier, B. (2001). Comment je traite une ascite. Revue Médicale de Liège, 56 (12), 809-815.
Peer reviewed

MAGGIPINTO, G., GERARD, C., JACQUES, J., LECRENIER, J., & BOUILLENNE, C. (August 2000). Use of MACE to detect and to confirm CDC negative HLA Class I specific antibodies. European Journal of Immunogenetics, 27 (4), 292.
Peer Reviewed verified by ORBi

Delwaide, J., Gerard, C., Belaiche, J., Maggipinto, G., Vaira, D., & Rentier, B. (2000). Evidence-Based Medicine: traitement de l'hépatite chronique C. GLEVHE. Groupe Liégeois d'Etude des Virus Hépatotropes. Revue Médicale de Liège, 55 (5), 337-340.
Peer reviewed

Delwaide, J., Gerard, C., Belaiche, J., Vaira, D., Maggipinto, G., & Rentier, B. (1999). La transmission du virus de l’hépatite C en milieu hospitalier. Médecine et Hygiène, 57, 1526-1529.
Peer Reviewed verified by ORBi

Lamproye, A., Delwaide, J., Vaira, D., Maggipinto, G., Gerard, C., Sondag, D., Rentier, B., Rorive, G., & Belaiche, J. (1999). Prevalence of hepatitis G virus in a haemodialysis unit. Acta Gastro-Enterologica Belgica, 62 (1), 13-15.
Peer Reviewed verified by ORBi

Delwaide, J., Gerard, C., Vaira, D., Maggipinto, G., Rentier, B., & Belaiche, J. (1999). Hepatitis C virus transmission following invasive medical procedures [letter to the editor]. Journal of Internal Medicine, 245 (1), 107-108. doi:10.1046/j.1365-2796.1999.0444f.x
Peer Reviewed verified by ORBi

Gerard, C., Vaira, D., Delwaide, J., Lamproye, A., Maggipinto, G., Sondag, D., Rorive, G., Belaiche, J., & Rentier, B. (1998). Does HCV screening of blood donors affect transmission of hepatitis G virus in dialysed patients? Vox Sanguinis, 75 (1), 77-77. doi:10.1046/j.1423-0410.1998.7510077.x
Peer Reviewed verified by ORBi

DELWAIDE, J., Gerard, C., Vaira, D., Maggipinto, G., Rentier, B., & Belaiche, J. (1998). Transmission du virus de l'hépatite C par examens médicaux invasifs. Gastroentérologie Clinique et Biologique, 22 (2), 172.
Peer Reviewed verified by ORBi

Vaira, D., Delwaide, J., Lamproye, A., Maggipinto, G., Gerard, C., Rorive, G., Sondag, D., Rentier, B., & Belaiche, J. (1997). Prévalence du virus de l'hépatite G dans une population d'hémodialysés chroniques [Paper presentation]. XXIèmes Journées Francophones de Pathologie Digestive, Strasbourg, France.

Vaira, D., Delwaide, J., Lamproye, A., Maggipinto, G., Gerard, C., Rorive, G., Belaiche, J., SondagThull, D., & Rentier, B. (1997). Hepatitis G virus (HGV) prevalence in a Belgian population of chronic hemodialyzed patients. Gut, 41 (Suppl. 3), 129-A130.
Peer Reviewed verified by ORBi

Gerard, C., Vaira, D., Maggipinto, G., Troonen, H., Margraff, U., Siquet, J., & Sondag, D. (1996). Combination of Serological Markers to Predict the Presence or Absence of Viremia in Hcv-Seropositive Blood Donors. Vox Sanguinis, 71 (1), 58-60. doi:10.1046/j.1423-0410.1996.7110058.x
Peer Reviewed verified by ORBi

Deneufbourg, J.-M., Bouillenne, C., MAGGIPINTO, G., & Lupo, A. (26 July 1992). Lymphocytes subsets before and after neoadjuvant polychemotherapy for head and neck cancers [Poster presentation]. 3rd International Conference on Head and Neck Cancer, San Francisco, United States - California.
Peer reviewed

Deneufbourg, J.-M., Bouillenne, C., MAGGIPINTO, G., & Lupo Aurélia. (November 1991). Changes of lymphocytes subsets after neoadjuvant chemotherapy for head and neck cancers. European Journal of Cancer and Clinical Oncology, 27 (suppl.3), 16. doi:10.1016/0277-5379(91)91160-k
Peer Reviewed verified by ORBi

Sebestyen, G., MAGGIPINTO, G., & André, A. (1986). Dosage des anticorps antitetaniques avec la proteine "A" marquee a l'iode 125. Revue Française de Transfusion et Immuno-Hematologie, 29 (5), 355-76. doi:10.1016/S0338-4535(86)80062-9
Peer Reviewed verified by ORBi

Contact ORBi